Colin Baigent - Concepedia

Author

Colin Baigent

Also Known As

, Baigent, C, Baigent, Colin, C Baigent, C. Baigent, Colin Baigent, Colin Baigent (Reino Unido), Colin N. Baigent, Elena Arbelo, Folkert W Asselbergs

350

Publications

90.6K

Citations

H-Index

101

Concepts

All Affiliations

University of Oxford Medical Research Council University College London The University of Sydney University of Glasgow

About

Colin Baigent is an author at University of Oxford specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	9.4K
2	Health Sciences	5	5	542
3	Nursing	3	4	121
4	Engineering	1	1	161
5	Law	1	1	125

Colin Baigent

111

Publications

30.6K

Citations

H-Index

Page 1

	Year	Citations
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i> François Mach, Colin Baigent, Alberico L. Catapano, European Heart Journal	2019	8.4K
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. R B Sleight, Peter Sleight, Sarah Parish, PubMed	1988	2.9K
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Colin Baigent, Martin Landray, Christina Reith, The Lancet Cardiovascular DiseaseMedicineAntihypertensive TherapyHyperlipidemiaLdl Cholesterol	2011	2.4K
ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. Robert T. Collins, R Peto, Marcus Flather, Ghent University Academic Bibliography (Ghent University) ThrombosisCardiovascular DiseasePharmacotherapyIntravenous Magnesium SulphateEarly Oral Captopril	1995	1.1K
Aspirin in Patients Undergoing Noncardiac Surgery P.J. Devereaux, Marko Mrkobrada, Daniel I. Sessler, New England Journal of Medicine	2014	913
Antiplatelet Drugs Carlo Patrono, Colin Baigent, Jack Hirsh, CHEST Journal	2008	740
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Marion Mafham, Enti Spata, Raph Goldacre, The Lancet	2020	737
Indications for ACE inhibitors in the early treatment of acute myocardial infarction - Systematic overview of individual data from 100,000 patients in randomized trials Maria Grazia Franzosi, Eugenio Santoro, Giulio Zuanetti, Circulation ThrombosisAce InhibitorsCardiovascular DiseaseAtherosclerosisCoronary Unit	1998	537
Cholesterol and the Risk of Renal Dysfunction in Apparently Healthy Men Elke Schäeffner, Tobias Kurth, Gary C. Curhan, Journal of the American Society of Nephrology	2003	442

Page 1